TY -
BOOK
AU - Mellinghoff, Ingo K.
AU - Sawyers, Charles L.
AU - Mellinghoff, Ingo Kai
TI -
Therapeutic kinase inhibitors
PB - Springer
SN - 9783642282959
SN - 3642282954
KW - Cancer Chemotherapy
KW - Antineoplastic agents
KW - Neoplasms drug therapy
KW - Protein Kinase Inhibitors therapeutic use
KW - Antineoplastic Agents therapeutic use
KW - Drug Discovery
KW - Adenosine Triphosphate therapeutic use
KW - Aufsatzsammlung
KW - Krebs Medizin
KW - Proteinkinasen
KW - Enzyminhibitor
PY - 2012
N2 - Literaturangaben
N2 - Setting up a kinase discovery and development project Gideon Bollag
N2 - Drug efficacy testing in mice William Y. Kim and Norman E. Sharpless
N2 - Gastrointestinal stromal tumors Cristina Antonescu
N2 - EGFR mutant lung cancer Yixuan Gong and William Pao
N2 - Targeting oncogenic BRAF in human cancer Christine A. Pratilas, Feng Xing and David B. Solit
N2 - Beyond BRAF in melanoma Adil Daud and Boris C. Bastain
N2 - JAK-mutant myeloproliferative neoplasms Ross L. Levine
N2 - Will kinase inhibitors make it as glioblastoma drugs? Ingo K. Mellinghoff ... [et al.]
N2 - Predictive genomic biomarkers Rakesh Kumar and Rafael G. Amado
N2 - Epigentic biomarkers Timothy A. Chan and Stephen B. Baylin
N2 - Adjuvant trials of targeted agents : the newest battleground in the war on cancer Robert L. Cohen.
BT - Current topics in microbiology and immunology ; 355
CY - Berlin
UR - http://slubdd.de/katalog?TN_libero_mab2
ER -